stem cells

New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Flag link:
Omeros hits endpoint in pivotal stem cell transplant study
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Omeros
narsoplimab
stem cells
stem cell transplant
clinical trials
Flag link:
Stem Cell Therapy Works for Cardiac Patients, But Not in the Way We Think
Stem Cell Therapy Works for Cardiac Patients, But Not in the Way We Think
Xtalks
stem cells
Cardiac
heart attack
Flag link:
ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer
ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer
Fierce Biotech
ExCellThera
umbilical cord blood
cord blood
stem cells
blood cancers
Flag link:
ReNeuron shares clinical data on stem cell vision loss therapy
ReNeuron shares clinical data on stem cell vision loss therapy
Fierce Biotech
ReNeuron
stem cells
Retinitis pigmentosa
vision loss
Flag link:
How Viagra could boost a widely used blood cancer treatment
How Viagra could boost a widely used blood cancer treatment
Fierce Biotech
Viagra
Pfizer
stem cells
bone marrow
blood cancer
Sanofi
Mozobil
Flag link:
Lawmakers press Sharpless to bring stem cell companies into line
Lawmakers press Sharpless to bring stem cell companies into line
BioCentury
FDA
stem cells
Ned Sharpless
Flag link:
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
BioSpace
Takeda
Kyoto University
CAR-T
stem cells
Flag link:
Here's Why Athersys Is Soaring Today
Here's Why Athersys Is Soaring Today
Motley Fool
Athersys
Japan
clinical trials
stem cells
MultiStem
ARDS
Flag link:
Mesoblast poised to file cell therapy for GVHD in US
Mesoblast poised to file cell therapy for GVHD in US
Pharmaforum
Mesoblast
stem cells
graft vs host disease
FDA
remestemcel-L
Flag link:
Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead
Off-the-shelf CAR-T from stem cells? An early look at UCLA tech — licensed by Gilead
Endpoints
CAR-T
Gilead Sciences
UCLA
stem cells
Flag link:
Korean biotechs snatch U.S. stem cell manufacturing facility
Korean biotechs snatch U.S. stem cell manufacturing facility
Fierce Pharma
Korea
stem cells
Flag link:
Daiichi Sankyo takes option on diabetes stem cell start-up
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
Flag link:
How Miniature Human Hearts Will Revolutionize Drug Testing
How Miniature Human Hearts Will Revolutionize Drug Testing
Forbes
drug safety
stem cells
Flag link:
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later
Xconomy
ViaCyte
stem cells
diabetes
IPOs
clinical trials
Flag link:
Mesoblast defends stem cell therapy for heart failure after trial miss
Mesoblast defends stem cell therapy for heart failure after trial miss
Fierce Biotech
Mesoblast
stem cells
clinical trials
heart failure
Flag link:
Magenta stem cell transplant drug seems to work, but is it safe?
Magenta stem cell transplant drug seems to work, but is it safe?
Fierce Biotech
Magenta Therapeutics
MGTA-456
clinical trials
stem cells
Flag link:
NIH pauses stem cell trial after Brigham calls to retract 'fabricated' foundational research
NIH pauses stem cell trial after Brigham calls to retract 'fabricated' foundational research
BioCentury
NIH
stem cells
Brigham and Women's
Flag link:
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
CP Wire
Omeros
OMS721
stem cells
thrombotic microangiopathy
Flag link:
Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research
Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research
Stat
Harvard
Brigham and Women's
medical journals
stem cells
Flag link:

Pages